State Street’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $983K | Buy |
251,948
+166,919
| +196% | +$651K | ﹤0.01% | 3488 |
|
|
2025
Q1 | $322K | Hold |
85,029
| – | – | ﹤0.01% | 3711 |
|
|
2024
Q4 | $462K | Buy |
85,029
+16,300
| +24% | +$88.5K | ﹤0.01% | 3639 |
|
|
2024
Q3 | $288K | Hold |
68,729
| – | – | ﹤0.01% | 3733 |
|
|
2024
Q2 | $203K | Buy |
68,729
+2,100
| +3% | +$6.2K | ﹤0.01% | 3825 |
|
|
2024
Q1 | $185K | Hold |
66,629
| – | – | ﹤0.01% | 3889 |
|
|
2023
Q4 | $189K | Hold |
66,629
| – | – | ﹤0.01% | 3913 |
|
|
2023
Q3 | $172K | Hold |
66,629
| – | – | ﹤0.01% | 3978 |
|
|
2023
Q2 | $288K | Hold |
66,629
| – | – | ﹤0.01% | 3888 |
|
|
2023
Q1 | $102K | Hold |
66,629
| – | – | ﹤0.01% | 4320 |
|
|
2022
Q4 | $105K | Hold |
66,629
| – | – | ﹤0.01% | 4357 |
|
|
2022
Q3 | $83K | Hold |
66,629
| – | – | ﹤0.01% | 4527 |
|
|
2022
Q2 | $135K | Hold |
66,629
| – | – | ﹤0.01% | 4375 |
|
|
2022
Q1 | $167K | Buy |
66,629
+6,912
| +12% | +$17.3K | ﹤0.01% | 4449 |
|
|
2021
Q4 | $223K | Buy |
59,717
+20,000
| +50% | +$74.7K | ﹤0.01% | 4303 |
|
|
2021
Q3 | $159K | Buy |
39,717
+9,500
| +31% | +$38K | ﹤0.01% | 4428 |
|
|
2021
Q2 | $134K | Buy |
+30,217
| New | +$134K | ﹤0.01% | 4307 |
|